Skip to main content
. 2023 May 22;11(5):e006230. doi: 10.1136/jitc-2022-006230

Table 1.

Correlation between the expression of NR_109 in CD163+ TAMs and clinicopathological characteristics in GC and BC

Parameters Expression of NR_109 in TAMs P value
GC Low (%) High (%)
Age/year 0.694
<60 3 (30) 7 (70)
≥60 9 (45) 11 (55)
Gender 0.024*
Male 12 (52) 11 (48)
Female 0 (0) 7 (100)
Grade 0.669
Ⅰ–Ⅱ 10 (43) 13 (57)
2 (29) 5 (71)
Tumor size 0.711
≤5 cm 6 (46) 7 (54)
>5 cm 6 (35) 11 (65)
Lymph node 0.045*
No 7 (70) 3 (30)
Yes 5 (25) 15 (75)
TNM stage 1.000
Ⅰ–Ⅱ 6 (40) 9 (60)
Ⅲ–IV 6 (40) 9 (60)
BC
Age/year 0.882
≤70 21 (48) 23 (52)
>70 7 (50) 7 (50)
Grade 0.786
Ⅰ–Ⅱ 15 (50) 15 (50)
13 (46) 15 (54)
Tumor size 1.000
≤4 cm 25 (49) 26 (51)
>4 cm 3 (43) 4 (57)
Lymph node 0.754
No 17 (50) 17 (50)
Yes 11 (46) 13 (54)
TNM stage 0.036*
Ⅰ–Ⅱ 23 (58) 17 (42)
Ⅲ–IV 5 (28) 13 (72)

The χ2-tests were used. *The values had statistically significant differences.

*The values had statistically significant differences.

BC, breast cancer; GC, gastric cancer; TAMs, tumor-associated macrophages.